Tislelizumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer

NCT05588219 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Uterine Cervical Neoplasms

Interventions

DRUG: Tislelizumab
DRUG: DDP synchronous with radiotherapy

Sponsor

Yong Zhang,MD